tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market

CNS Pharmaceuticals (CNSP) Stock Investors

797 Followers
Based on 729,232 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CNSP
On average, investors allocate 0.00% of their portfolios to CNSP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 729,232 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CNSP

1.9%
Last 7
Days
3.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CNSP, out of 729,232 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CNSP Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$0.40
Based on the activity of 13,704 investors who made their portfolios public
The table shows changes in CNSP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CNSP Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
3.89%
-0.93%
-7.35%
575.77M
Consumer Cyclical
AMC Entertainment
5.44%
-0.60%
-6.73%
832.99M
Communication Services
Riot Platforms
4.94%
-0.10%
-1.04%
2.31B
Financial
Marathon Digital Holdings
5.49%
-0.58%
-3.33%
4.66B
Financial
Plug Power
4.90%
-0.90%
-6.55%
1.76B
Industrials
GE Aerospace
5.50%
+0.90%
+6.06%
161.87B
Industrials
Blink Charging Co
5.06%
-1.11%
-7.30%
231.28M
Industrials
Block
4.46%
-0.90%
-7.52%
43.36B
Technology
Coherus Biosciences
2.64%
-1.06%
-8.48%
234.94M
Healthcare
Li Auto
5.53%
-1.23%
-5.77%
26.95B
Consumer Cyclical
Based on the activity of 729,232 active portfolios
Open your Smart Portfolio

CNSP Investor Analysis

CNSP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.0%
of CNSP holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
CNSP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.8%
of CNSP holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
CNSP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.2%
of CNSP holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of CNSP stock investors
See who invests in CNSP according to age group and performance.

FAQ

How many retail Investors hold CNSP?
<0.1% of TipRanks' retail investors hold CNSP in their portfolios.
    What is CNSP Investor Sentiment?
    CNSP’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CNSP in the last 7 days?
      ▲ 1.9% of TipRanks' retail investors changed their holding of CNSP in the last 7 days.
        What percentage of retail investors changed their holding of CNSP in the last 30 days?
        ▲ 3.1% of TipRanks' retail investors changed their holding of CNSP in the last 30 days.
          What is the average age of retail investors who hold CNSP?
          The average age of CNSP Holders is between 35–55.
            What other stocks have CNSP investors also bought?
            CNSP Investors also bought CHPT, AMC, RIOT, MARA, PLUG, GE, BLNK, SQ, CHRS, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis